切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2021, Vol. 15 ›› Issue (05) : 501 -505. doi: 10.3877/cma.j.issn.1674-3946.2021.05.010

论著

腹腔镜胆胰转流十二指肠转位术治疗中国肥胖患者可行性研究的初步探讨
王伦1, 贾永恒1, 姜涛1,(), 任昭恒1, 王泽雨1   
  1. 1. 130033 吉林省长春市 吉林大学中日联谊医院减重代谢外科
  • 收稿日期:2021-03-22 出版日期:2021-10-26
  • 通信作者: 姜涛

Preliminary study of laparoscopic biliopancreatic diversion with duodenal switch in the treatment of Chinese patients with obesity

Lun Wang1, Yongheng Jia1, Tao Jiang1,(), Zhaoheng Ren1, Zeyu Wang1   

  1. 1. Department of Bariatric and Metabolic Surgery, China-Japan Union Hospital, Jilin University, Changchun 130033, China
  • Received:2021-03-22 Published:2021-10-26
  • Corresponding author: Tao Jiang
  • Supported by:
    Science Project Funded by the Financial Department of Jilin Province(2018SCZ032)
引用本文:

王伦, 贾永恒, 姜涛, 任昭恒, 王泽雨. 腹腔镜胆胰转流十二指肠转位术治疗中国肥胖患者可行性研究的初步探讨[J]. 中华普外科手术学杂志(电子版), 2021, 15(05): 501-505.

Lun Wang, Yongheng Jia, Tao Jiang, Zhaoheng Ren, Zeyu Wang. Preliminary study of laparoscopic biliopancreatic diversion with duodenal switch in the treatment of Chinese patients with obesity[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2021, 15(05): 501-505.

目的

初步探讨腹腔镜胆胰转流十二指肠转位术(BPD/DS)治疗中国肥胖患者的可行性及安全性。

方法

回顾性分析2019年9月至2020年1月期间11例接受BPD/DS治疗的肥胖症患者的临床资料。分析患者术后1年的各项指标。用SPSS 22.0统计软件进行分析。计量资料以(±s)表示,正态分布的计量资料采用配对t检验,偏态分布的计量资料采用Mann-Whitney U检验。P<0.05为差异有统计学意义。

结果

所有患者均成功施行BPD/DS,无中转开腹及死亡病例。术后1年的随访率为81.8%(9/11)。以下是术后1年的结果:体重、体质量指数分别为(77.3±15.8) kg和(25.6±5.3) kg/m2,较术前均显著下降(P<0.05);收缩压、舒张压分别为(119.3±17.2) mmHg和(76.1±13.4) mmHg,较前术前均显著降低(P<0.05),高血压缓解率为77.7%(7/9);高尿酸血症缓解率为66.7%(4/6);术后1年的2型糖尿病缓解率为100.0%(4/4);术前异常升高的总胆固醇、甘油三酯和低密度脂蛋白在术后1年的缓解率分别为100.0%(4/4)、100.0%(3/3)和100.0%(6/6)。共5例患者出现并发症:术后腹腔出血1例、十二指肠回肠吻合口漏1例、小肠梗阻1例、慢性贫血(Hb:97.0g/L)1例、慢性肝实质损害1例。术后1年获得随访的9例患者的锌、维生素E、叶酸、白蛋白较术前均显著下降(P<0.05),其低于正常值范围的百分比分别为44.4%(4/9)、55.5%(5/9)、0%(0/9)、22.2%(2/9)。9例患者术后1年的血清氯较术前显著升高(P<0.05)。

结论

虽然BPD/DS对肥胖及其代谢病具有十分可观的疗效,但该术式的并发症发生率较高,可行性及安全性欠佳,需慎重开展该术式。

Objective

To investigate the feasibility and safety of laparoscopic biliopancreatic diversion with duodenal switch(BPD/DS) preliminarily in the treatment of Chinese patients with obesity.

Methods

The clinical data of eleven patients with obesity treated with BPD/DS from September 2019 to January 2020 were analyzed retrospectively.We analyzed each index at one year after operation. Statistical analysis were performed by using SPSS 22.0 software. Measurement data were expressed as (±s). They were examined by using paired t test (Normality data) or Mann-Whitney U test (skewed data), as appropriate. A P value of <0.05 was considered as statistically significant difference.

Results

All of 11 patients underwent successfully BPD/DS without conversion to laparotomy or perioperative death. The follow-up rate at 1 year after surgery was 81.8% (9/11). The results in the first postoperative year were as follows: The body weight and body mass index were (77.3±15.8) kg and (25.6±5.3) kg/m2, which decreased significantly than those of before operation respectively (P<0.05). The systolic blood pressure and diastolic blood pressure were (119.3±17.2) mmHg and (76.1±13.4) mmHg, which decreased significantly than those before operation respectively (P<0.05), and the remission rate of hypertension was 77.7% (7/9). The remission rate of hyperuricemia was 66.7% (4/6). The remission rate of type 2 diabetes mellitus 1 year after operation was 100.0% (4/4). The remission rate of total cholesterol, triglycerides, and low-density lipoprotein over the normal upper limit before operation were 100.0% (4/4), 100.0% (3/3), and 100.0% (6/6) at 1 year after surgery. There were five complications in total: 1 case of postoperative intraperitoneal hemorrhage, 1 case of duodenal-ileal anastomotic leakage, 1 case of intestinal obstruction, 1 case of chronic anemia (Hb: 97.0g/L) and 1 case of chronic hepatic parenchyma damage. The level of zinc, vitamin E, folic acid, and albumin of the 9 patients who were followed up in the first postoperative year decreased significantly than those before operation (P<0.05), and their percentages below the normal range were 44.4% (4/9), 55.5% (5/9), 0% (0/9) and 22.2% (2/9). The serum chlorine level of 9 patients at 1 year after operation increased significantly than those before operation respectively (P<0.05).

Conclusion

Although laparoscopic biliopancreatic diversion with duodenal switch is considered as giving a significant curative effect on obesity and its-related metabolic diseases, the complication rate of this operation is relatively high. Therefore, it needs to be carefully to carry out this procedure because the feasibility and safety of BPD/DS are not good.

图1 BPD/DS示意图[10](胃袖状切除是在34Fr胃管指引下进行,食物支通道长度为200 cm,食物与胆胰液混合的共同通道长度为100 cm)
表1 9例肥胖患者腹腔镜BPD/DS术前术后体重及代谢指标对比(±s)
表2 9例肥胖患者腹腔镜BPD/DS术前术后5项营养指标对比(±s)
[1]
张忠涛,张鹏. 腹腔镜减重与代谢外科治疗现状与发展[J/CD]. 中华普外科手术学杂志(电子版)202014(2):109-112.
[2]
朱晒红,李鹏洲,高祥,等. 腹腔镜减重代谢袖状胃手术要点与适应证[J/CD]. 中华普外科手术学杂志(电子版)202014(2):113-116.
[3]
Skogar ML, Sundbom M. Weight loss and effect on co-morbidities in the long-term after duodenal switch and gastric bypass: a population-based cohort study[J]. Surg Obes Relat Dis202016(1):17-23.
[4]
Yashkov Y, Bordan N, Torres A, et al. SADI-S 250 vs Roux-en-Y Duodenal Switch (RY-DS): Results of 5-Year Observational Study[J]. Obes Surg202131(2):570-579.
[5]
Baltasar A, Bou R, Perez N, et al. [Twenty-five years of duodenal switch. How to switch to the duodenal switch][J]. Nutr Hosp201936(6):1278-1287.
[6]
中国医师协会高血压专业委员会. 中国医师协会关于我国高血压诊断标准及降压目标科学声明[J]. 中国实用内科杂志201838(4):348-350.
[7]
中华医学会内分泌学分会. 中国高尿酸血症与痛风诊疗指南(2019)[J]. 中华内分泌代谢杂志202036(1):1-13.
[8]
American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020[J]. Diabetes Care202043(Suppl 1):S14-S31.
[9]
Brethauer SA, Kim J, el Chaar M, et al. Standardized outcomes reporting in metabolic and bariatric surgery[J]. Obes Surg201511(3): 489-506.
[10]
Anthone GJ, Lord RVN, DeMeester TR, et al. The duodenal switch operation for the treatment of morbid obesity[J]. Ann Surg2003238(4): 618-627; discussion 627-628.
[11]
Scopinaro N, Gianetta E, Civalleri D, et al. Bilio-pancreatic bypass for obesity: II. Initial experience in man[J]. Br J Surg197966(9):618-620.
[12]
Lagace M, Marceau P, Marceau S, et al. Biliopancreatic Diversion with a New Type of Gastrectomy: Some Previous Conclusions Revisited[J]. Obes Surg19955(4):411-418.
[13]
Hess D S, Hess D W. Biliopancreatic diversion with a duodenal switch[J]. Obes Surg19988(3):267-282.
[14]
Kapeluto JE, Tchernof A, Masckauchan D, et al. Ten-year remission rates in insulin-treated type 2 diabetes after biliopancreatic diversion with duodenal switch[J]. Surg Obes Relat Dis202016(11):1701-1712.
[15]
Angrisani L, Santonicola A, Iovino P, et al. IFSO Worldwide Survey 2016: Primary, Endoluminal, and Revisional Procedures[J]. Obes Surg201828(12):3783-3794.
[16]
Skogar ML, Sundbom M. Early complications, long-term adverse events, and quality of life after duodenal switch and gastric bypass in a matched national cohort[J]. Surg Obes Relat Dis202016(5):614-619.
[17]
Finno P, Osorio J, Garcia-Ruiz-de-Gordejuela A, et al. Single Versus Double-Anastomosis Duodenal Switch: Single-Site Comparative Cohort Study in 440 Consecutive Patients[J]. Obes Surg202030(9):3309-3316.
[18]
Oviedo RJ, Nayak T, Liu Y, et al. Laparoscopic Duodenal Switch Versus Roux-en-Y Gastric Bypass at a High-Volume Community Hospital: a Retrospective Cohort Study from a Rural Setting[J]. Obes Surg202131(2):659-666.
[19]
Pereira AM, Guimaraes M, Pereira SS, et al. Single and dual anastomosis duodenal switch for obesity treatment: a single-center experience[J]. Surg Obes Relat Dis202117(1):12-19.
[20]
Sneineh MA, Harel L, Elnasasra A, et al. Increased Incidence of Symptomatic Cholelithiasis After Bariatric Roux-En-Y Gastric Bypass and Previous Bariatric Surgery: a Single Center Experience[J]. Obes Surg202030(3):846-850.
[21]
Altieri MS, Yang J, Nie L, et al. Incidence of cholecystectomy after bariatric surgery[J]. Surg Obes Relat Dis201814(7):992-996.
[22]
Dincer M, Dogan F. The effect of concomitant cholecystectomy and sleeve gastrectomy on morbidity in high-risk obese patients with symptomatic gallstones[J]. Wideochir Inne Tech Maloinwazyjne201914(2):237-241.
[23]
Clapp B, Lee I, Liggett E, et al. Are Concomitant Operations During Bariatric Surgery Safe? An Analysis of the MBSAQIP Database[J]. Obes Surg202030(11):4474-4481.
[24]
Yardimci S, Coskun M, Demircioglu S, et al. Is Concomitant Cholecystectomy Necessary for Asymptomatic Cholelithiasis During Laparoscopic Sleeve Gastrectomy?[J]. Obes Surg201828(2):469-473.
[1] 曹迪, 张玉茹. 经腹腔镜生物补片修补直肠癌根治术后盆底疝1例[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 115-116.
[2] 杜晓辉, 崔建新. 腹腔镜右半结肠癌D3根治术淋巴结清扫范围与策略[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 5-8.
[3] 周岩冰, 刘晓东. 腹腔镜右半结肠癌D3根治术消化道吻合重建方式的选择[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 9-13.
[4] 张焱辉, 张蛟, 朱志贤. 留置肛管在中低位直肠癌新辅助放化疗后腹腔镜TME术中的临床研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 25-28.
[5] 王春荣, 陈姜, 喻晨. 循Glisson蒂鞘外解剖、Laennec膜入路腹腔镜解剖性左半肝切除术临床应用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 37-40.
[6] 李晓玉, 江庆, 汤海琴, 罗静枝. 围手术期综合管理对胆总管结石并急性胆管炎患者ERCP +LC术后心肌损伤的影响研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 57-60.
[7] 甄子铂, 刘金虎. 基于列线图模型探究静脉全身麻醉腹腔镜胆囊切除术患者术后肠道功能紊乱的影响因素[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 61-65.
[8] 逄世江, 黄艳艳, 朱冠烈. 改良π形吻合在腹腔镜全胃切除消化道重建中的安全性和有效性研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 66-69.
[9] 李凯, 陈淋, 向涵, 苏怀东, 张伟. 一种U型记忆合金线在经脐单孔腹腔镜阑尾切除术中的临床应用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 15-15.
[10] 唐健雄, 李绍杰. 不断推进中国腹腔镜疝手术规范化[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 591-594.
[11] 田文, 杨晓冬. 腹腔镜腹股沟疝修补术式选择及注意事项[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 595-597.
[12] 李涛, 陈纲, 李世拥. 腹腔镜下右侧腹股沟斜疝修补术(TAPP)[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 598-598.
[13] 易明超, 汪鑫, 向涵, 苏怀东, 张伟. 一种T型记忆金属线在经脐单孔腹腔镜胆囊切除术中的临床应用[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 599-599.
[14] 李博, 胡刚, 邱文龙, 汤坚强, 王锡山. 多功能吲哚菁绿近红外荧光血管成像技术在腹腔镜直肠癌经自然腔道取标本手术(NOSES Ⅳ式)中的应用(附视频)[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 524-528.
[15] 孙秀艳, 徐庆蕾, 马鹏涛, 胡志元, 郭传真, 祝成红. 腹腔镜胃癌根治术中患者体温变化与压力性损伤及受压部位微环境的相关性分析[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 480-484.
阅读次数
全文


摘要